Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
56,940published records in database
4recall categories represented
Jun 28, 2023newest stored source record
Latest records
Latest recalls — page 552
The newest recall records with useful source details are listed here.
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)
There is a rare potential for reduced- or no-energy output during high voltage (HV) therapy (typically 0-12J) in implantable cardioverter defibrillators (ICDs) and cardiac resynchronization…
Class IFDA: OngoingMedtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)